Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Extended follow-up report of a randomized phase II trial comparing gemcitabine and cisplatin with or without berzosertib in patients with advanced urothelial carcinoma.
Extended follow-up report of a randomized phase II trial comparing gemcitabine and cisplatin with or without berzosertib in patients with advanced urothelial carcinoma. Parikh, M., Pal, S., Frankel, P., Ruel, C., Mortazavi, A., Milowsky, M. I., Vaishampayan, U. N., Lyou, Y., Wang, P., Parikh, R., Teply, B. A., Dreicer, R., Emamekhoo, H., Michaelson, D., Hoimes, C. J., Zhang, T., Srinivas, S., Kim, W. Y., Liu, G., Lara, P. N. LIPPINCOTT WILLIAMS & WILKINS. 2024: 614View details for DOI 10.1200/JCO.2024.42.4_suppl.614
View details for Web of Science ID 001266676900627